Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Glenmede Trust Co. NA

Glenmede Trust Co. NA grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 1.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 559,494 shares of the pharmacy operator’s stock after acquiring an additional 6,227 shares during the quarter. Glenmede Trust Co. NA owned about 0.06% of Walgreens Boots Alliance worth $17,565,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. Captrust Financial Advisors grew its stake in shares of Walgreens Boots Alliance by 16.9% in the third quarter. Captrust Financial Advisors now owns 166,776 shares of the pharmacy operator’s stock valued at $5,237,000 after buying an additional 24,077 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund grew its stake in shares of Walgreens Boots Alliance by 5.0% in the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 25,707 shares of the pharmacy operator’s stock valued at $807,000 after buying an additional 1,213 shares in the last quarter. Kentucky Retirement Systems grew its stake in shares of Walgreens Boots Alliance by 5.5% in the third quarter. Kentucky Retirement Systems now owns 56,151 shares of the pharmacy operator’s stock valued at $1,763,000 after buying an additional 2,941 shares in the last quarter. Avenir Corp grew its stake in shares of Walgreens Boots Alliance by 13.4% in the third quarter. Avenir Corp now owns 483,508 shares of the pharmacy operator’s stock valued at $15,182,000 after buying an additional 57,314 shares in the last quarter. Finally, Alpha Paradigm Partners LLC grew its stake in shares of Walgreens Boots Alliance by 22.8% in the third quarter. Alpha Paradigm Partners LLC now owns 15,293 shares of the pharmacy operator’s stock valued at $480,000 after buying an additional 2,844 shares in the last quarter. 56.71% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Walgreens Boots Alliance news, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction on Friday, November 18th. The stock was sold at an average price of $40.19, for a total transaction of $414,077.57. Following the sale, the executive vice president now owns 27,916 shares of the company’s stock, valued at approximately $1,121,944.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction on Friday, November 18th. The stock was sold at an average price of $40.19, for a total transaction of $414,077.57. Following the transaction, the executive vice president now directly owns 27,916 shares in the company, valued at approximately $1,121,944.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Nancy M. Schlichting sold 16,570 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total value of $660,977.30. Following the transaction, the director now owns 5,515 shares in the company, valued at $219,993.35. The disclosure for this sale can be found here. Company insiders own 17.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Evercore ISI lowered their target price on Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating for the company in a research note on Monday, October 3rd. Royal Bank of Canada lowered their price objective on Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating for the company in a research note on Wednesday, October 19th. Morgan Stanley restated an “underweight” rating and set a $39.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, November 23rd. Truist Financial lowered their price objective on Walgreens Boots Alliance from $44.00 to $42.00 and set a “hold” rating for the company in a research note on Thursday, January 19th. Finally, Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $43.00 to $54.00 in a research note on Tuesday, November 22nd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $43.46.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded up $0.20 during trading hours on Wednesday, reaching $36.10. 1,536,534 shares of the stock were exchanged, compared to its average volume of 7,273,027. The stock has a market capitalization of $31.14 billion, a P/E ratio of -10.44, a P/E/G ratio of 1.63 and a beta of 0.75. Walgreens Boots Alliance, Inc. has a 52 week low of $30.39 and a 52 week high of $51.51. The company has a quick ratio of 0.36, a current ratio of 0.70 and a debt-to-equity ratio of 0.32. The firm has a 50 day simple moving average of $38.86 and a 200-day simple moving average of $37.22.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last announced its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.01. The business had revenue of $33.38 billion for the quarter, compared to the consensus estimate of $33.04 billion. Walgreens Boots Alliance had a positive return on equity of 13.57% and a negative net margin of 2.24%. The business’s revenue was down 1.5% on a year-over-year basis. During the same quarter last year, the business posted $1.68 EPS. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 12th. Investors of record on Tuesday, November 15th were issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 5.32%. The ex-dividend date was Monday, November 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -55.81%.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.